Modern medicine is experiencing a period of significant advancements and innovations, and at its core is radiopharmaceuticals ...

Cubital tunnel syndrome. American Society for Surgery of the Hand. Carpal boss. Healey JH, Bernthal NM, van de Sande M. Management of tenosynovial giant cell tumor: a neoplastic and inflammatory ...

The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

The journey that led to the creation of the Extraordinary Healer Award for Oncology Nursing began with a simple, yet profound ...

An expert sat down to discuss the emotional and physical barriers patients may face when seeking support for fear of cancer progression. Emotional barriers patients face when communicating with their ...

continues to offer clinically meaningful symptom relief with extended use in patients with tenosynovial giant cell tumors (TGCT). These study results were published in The Oncologist. After a ...

c. In our new analysis of the tumor microenvironment, we have shown that SCellBOW effectively differentiates between malignant and non-malignant cells, confirming that it is not biased by the immune ...

Roche revealed in its first-quarter results statement that giredestrant missed the mark in the phase 2 acelERA trial in advanced breast cancer, in what appears to be another blow to the emerging ...

--(BUSINESS WIRE)--BrainChild Bio, Inc., a clinical-stage biotechnology company developing CAR T-cell therapies to treat tumors in the central nervous system (CNS), today announced that the ...